These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3349719)

  • 21. [Extraosseous nuclide uptake during skeletal scintigraphy. Heparin-calcium-induced 99mTc-HMDP accumulation].
    Baum RP; Brandhorst I; Maul FD; Hör G
    Rofo; 1985 Aug; 143(2):247-9. PubMed ID: 2992051
    [No Abstract]   [Full Text] [Related]  

  • 22. Soft tissue uptake on Tc-99m MDP bone scan after cardioversion.
    Vanhecke W; Merckx E; De Roo M; Mortelmans L
    Clin Nucl Med; 1989 Dec; 14(12):923. PubMed ID: 2605853
    [No Abstract]   [Full Text] [Related]  

  • 23. What do we want from a bone-scanning agent?
    Fogelman I; Bessent RG
    J Nucl Med; 1980 Mar; 21(3):296. PubMed ID: 6445001
    [No Abstract]   [Full Text] [Related]  

  • 24. [Whole body bone scintigram with 99mTc-HMDP (technetium-99m-hydroxy methylene diphosphonate) (author's transl)].
    Isobe Y; Ko S; Umegaki Y; Takahashi S; Kawaguchi N; Wada S; Matsumoto S
    Radioisotopes; 1981 Nov; 30(11):606-8. PubMed ID: 7335900
    [No Abstract]   [Full Text] [Related]  

  • 25. [Extraosseous tumor uptake of 99m-Tc-MDP].
    Hayasaka K; Sugie H; Saitoh Y; Arakawa K; Amoh K
    Rinsho Hoshasen; 1985 Jan; 30(1):61-5. PubMed ID: 3157814
    [No Abstract]   [Full Text] [Related]  

  • 26. Technetium-99m MDP uptake in chronic venous insufficiency.
    Lucas-Fehm LM; Makler PT; Shapiro B
    Clin Nucl Med; 1986 Nov; 11(11):803. PubMed ID: 3791792
    [No Abstract]   [Full Text] [Related]  

  • 27. Introduction of bone imaging agent into the pleural space.
    Spencer RP; Karimeddini MK
    Clin Nucl Med; 1986 Apr; 11(4):290. PubMed ID: 3956046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tc-99m MDP bone imaging in inflammatory enthesopathy.
    Aburano T; Yokoyama K; Taki J; Nakajima K; Tonami N; Hisada K
    Clin Nucl Med; 1990 Feb; 15(2):105-6. PubMed ID: 2311317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bone scintigraphy with Tc 99m MDP in the study of late complications of total hip prosthesis].
    Tarozzi C; Furno A; Fagioli G; Arguello JM; Miglietta A; Specchia L; Ruggieri N; Rimondi E; De Benedittis M; Galletti S
    Chir Organi Mov; 1984; 69(1):57-64. PubMed ID: 6237892
    [No Abstract]   [Full Text] [Related]  

  • 30. A crossover study comparing Tc-99m-labeled HMDP and MDP in patients.
    Rosenthall L; Arzoumanian A; Damtew BU; Tremblay J
    Clin Nucl Med; 1981 Aug; 6(8):353-5. PubMed ID: 6455231
    [No Abstract]   [Full Text] [Related]  

  • 31. Accumulation of a bone imaging agent in liver metastases from prostate carcinoma.
    Haseman MK
    Clin Nucl Med; 1983 Oct; 8(10):488-9. PubMed ID: 6228362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal intense skeletal radiotracer uptake on myocardial perfusion imaging with Tc-99m sestamibi.
    Gowda A; Peddinghaus L; Shandilya V; Gavriluke A; Jain D
    J Nucl Cardiol; 2006; 13(3):427-31. PubMed ID: 16750787
    [No Abstract]   [Full Text] [Related]  

  • 33. Technetium-99m MDP vs technetium-99m dicarboxypropane diphosphonate. A clinical comparison in various pathologic conditions.
    Godart G; Durez M; Bevilacqua M; Abramovici J; Robience Y
    Clin Nucl Med; 1986 Feb; 11(2):92-7. PubMed ID: 3769350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Technetium - 99M methylene-diphosphonate bone scan: mechanisms and clinical applications.
    Tan KF; Chang CH
    Singapore Med J; 1982 Apr; 23(2):61-72. PubMed ID: 6215712
    [No Abstract]   [Full Text] [Related]  

  • 35. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gallbladder visualization on a technetium-99m MDP bone scan.
    Lisann NM; Palestro CJ; Novich IS; Benua RS
    Clin Nucl Med; 1986 Jan; 11(1):57-8. PubMed ID: 3943247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accumulation of technetium-99m MDP in a cavernous hemangioma of the liver.
    Burkhalter JL; Morano JU; Patel BR
    Clin Nucl Med; 1986 Jul; 11(7):498-500. PubMed ID: 3731650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A parathyroid tumour demonstrated by bone scintigraphy.
    Feenstra H; Leytens J; Jöbsis AC; Van Royen EA
    Neth J Med; 1983; 26(3):88-90. PubMed ID: 6221197
    [No Abstract]   [Full Text] [Related]  

  • 39. Tc-99m MDP bone scintigraphy in septic shock.
    Chicklore S; Bashir H; Vijayanathan S; Gnanasegaran G
    Clin Nucl Med; 2009 Nov; 34(11):834-5. PubMed ID: 19851193
    [No Abstract]   [Full Text] [Related]  

  • 40. Unusual persistence of Tc-99m MDP uptake in the incisional scar after thoracotomy.
    Shih WJ; DeLand FH; Domstad PA; Dillon ML
    Clin Nucl Med; 1984 Oct; 9(10):596-7. PubMed ID: 6237824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.